Evofem Biosciences (EVFM) News Today $0.01 0.00 (0.00%) (As of 11:50 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024November 16, 2024 | finanznachrichten.deEvofem Biosciences Reports Q3 2024 Financial ResultsNovember 15, 2024 | markets.businessinsider.comEvofem Biosciences Announces Financial Results for the Third Quarter of 2024November 14, 2024 | prnewswire.comEvofem Biosciences Secures Investor Support through Voting AgreementsNovember 14, 2024 | americanbankingnews.comAditxt announces Evofem secures voting agreements with investors for mergerNovember 6, 2024 | markets.businessinsider.comEvofem Secures Investor Support for Proposed Merger through Voting AgreementsNovember 6, 2024 | prnewswire.comEvofem Biosciences Faces Merger and Credit ChallengesNovember 1, 2024 | markets.businessinsider.comAditxt Completes Final Equity Investment and Key Milestone Under the Amended and Restated Merger Agreement with EvofemOctober 28, 2024 | finance.yahoo.comAditxt and Evofem partner to launch endometriosis diagnostic in 2025September 24, 2024 | msn.comEvofem Biosciences Files Preliminary Proxy for Stockholder Approval of the Acquisition by AditxtSeptember 24, 2024 | finance.yahoo.comAditxt’s Subsidiary Pearsanta to Collaborate with Evofem Biosciences for Targeted U.S. Launch of Endometriosis Diagnostic in Mid-2025September 20, 2024 | finance.yahoo.comInvestorNewsBreaks – Aditxt (NASDAQ: ADTX) Subsidiary Signs Agreement with Evofem Biosciences Inc. (OTCQB: EVFM) Involving Unique Endometriosis Diagnostic TestSeptember 20, 2024 | msn.comAditxt and Evofem Sign Second Amendment to Amended and Restated Merger Agreement, Target Closing of Acquisition in Fourth Quarter of 2024September 9, 2024 | uk.finance.yahoo.comEvofem Biosciences Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral SolutionAugust 20, 2024 | prnewswire.comEvofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Second Quarter of 2024August 15, 2024 | finanznachrichten.deEvofem Biosciences Announces Financial Results for the Second Quarter of 2024August 14, 2024 | prnewswire.comEvofem Biosciences to Present at the OTCQB Venture Virtual Investor Conference on August 1stJuly 25, 2024 | globenewswire.comEvofem Signs Phexxi® License Agreement for Middle East with Pharma 1July 23, 2024 | prnewswire.comLupin Divests U.S. Commercial Women's Health Specialty Business to Evofem, including SOLOSECJuly 15, 2024 | prnewswire.comHello Alpha Partners with Evofem to Offer Phexxi® as a Hormone-Free Contraception Solution on its Platform for Women's HealthcareJune 27, 2024 | prnewswire.comEvofem Announces Issuance of New U.S. Patent Covering Phexxi Composition of MatterJune 11, 2024 | prnewswire.comEVFM Stock Earnings: Evofem Biosciences Reported Results for Q1 2024May 15, 2024 | investorplace.comEvofem Biosciences Announces Financial Results for the First Quarter of 2024May 15, 2024 | prnewswire.comEvofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTOApril 18, 2024 | prnewswire.comEvofem Biosciences, Inc. (EVFM)April 17, 2024 | finance.yahoo.comEvofem Biosciences, Inc. (EVFM) stock forecast and price targetApril 17, 2024 | finance.yahoo.comEVFM Stock Earnings: Evofem Biosciences Reported Results for Q4 2023March 27, 2024 | msn.comEvofem Reports $18.2 million of Phexxi Net Product Sales in 2023March 27, 2024 | prnewswire.comEvofem Biosciences, Inc.: Evofem Negotiates Improved Rebate for Hormone-Free "In the Moment" Contraceptive PHEXXI with Medi-CalMarch 20, 2024 | finanznachrichten.deFor Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended PregnancyMarch 7, 2024 | prnewswire.comEvofem Biosciences Stock (OTC:EVFM) Insider TradesFebruary 23, 2024 | benzinga.comEvofem Biosciences Stock (OTC:EVFM), Short Interest ReportFebruary 23, 2024 | benzinga.comEvofem Biosciences Inc (EVFM)February 13, 2024 | investing.comAditxt, Inc. Restructures Debt Post-Merger with EvofemFebruary 7, 2024 | markets.businessinsider.comEvofem Biosciences Announces Merger Agreement with AditxtFebruary 1, 2024 | msn.comEvofem Biosciences achieves 2023 prelim net product sales of $18.1M to $18.3MFebruary 1, 2024 | msn.comEvofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023February 1, 2024 | finance.yahoo.comWashington State HCA Removes Prior Authorization for Hormone-Free "In the Moment" Contraceptive PHEXXI Ahead of Huskies vs. Wolverines Championship GameJanuary 8, 2024 | finance.yahoo.comEvofem Biosciences Inc EVFMJanuary 3, 2024 | morningstar.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, EVFM, AEZS, HOLIDecember 19, 2023 | markets.businessinsider.comEVOFEM BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Evofem Biosciences, Inc. - EVFMDecember 18, 2023 | businesswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSTR, CVLY, EVFM, EARDecember 13, 2023 | markets.businessinsider.comEvofem just downgraded at Laidlaw, here's whyDecember 12, 2023 | realmoney.thestreet.comShares of Aditxt, Evofem Surge on $100 Million Acquisition DealDecember 12, 2023 | marketwatch.comAditxt To Acquire Evofem For $100 Mln; ADTX Stock SoarDecember 12, 2023 | markets.businessinsider.comEVFM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Evofem Biosciences, Inc. Is Fair to ShareholdersDecember 12, 2023 | tmcnet.comAditxt to acquire women’s health company Evofem BiosciencesDecember 12, 2023 | msn.comAditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi®, the First and Only FDA-Approved Hormone-Free Contraceptive Gel, to Address Diverse Reproductive Health Needs of Women GloballyDecember 12, 2023 | finance.yahoo.comEvofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2023November 14, 2023 | finanznachrichten.deEvofem Biosciences GAAP EPS of $0.10, revenue of $5.11MNovember 14, 2023 | msn.com Get Evofem Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVFM and its competitors with MarketBeat's FREE daily newsletter. Email Address New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! EVFM Media Mentions By Week EVFM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVFM News Sentiment▼0.320.47▲Average Medical News Sentiment EVFM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVFM Articles This Week▼31▲EVFM Articles Average Week Get Evofem Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVFM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Pasithea Therapeutics News Sonoma Pharmaceuticals News Tharimmune News China Pharma News Avenue Therapeutics News Genetic Technologies News Artelo Biosciences News Synaptogenix News Gritstone bio News Purple Biotech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVFM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evofem Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evofem Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
